series-c-plus
Stage
1
Investors
About
TYK Medicines is a China-based biopharmaceutical company focused on the research and development of innovative targeted small molecule drugs, especially for the treatment of lung cancer brain metastasis.
Explore TYK Medicines's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.